Glucose monitoring in diabetes: from clinical studies to real‐world practice

Lowering glucose levels in diabetes prevents microvascular complications and long‐term macrovascular disease. HbA 1c has long been used to guide management decisions, but it fails to address hypoglycaemia and glycaemic variability, both of which are associated with adverse clinical outcome. While self‐monitoring of blood glucose (SMBG) has had a pivotal role in improving glycaemia in diabetes, it provides incomplete glucose data and can be...